SupplyScape and VeriSign Announce Interoperability
of E-Pedigree Solutions
Woburn, MA. and Mountain View, CA., February 7, 2006 -- SupplyScape
Corporation and VeriSign, Inc. (Nasdaq: VRSN), two organizations that
are leading the development and deployment of electronic pedigree solutions,
today announce pedigree interoperability in advance of an industry-wide
standard. Both organizations are participating in industry efforts
to define a standard for communicating pedigree information and anticipate
supporting those standards when they are ratified.
Members of the pharmaceutical supply chain need interoperability
to enable electronic pedigrees in compliance with emerging state regulations.
Florida will require that all wholesale trading partners use pedigrees
beginning July 1, 2006. A similar law comes into effect in California
on January 1, 2007. Ten other states have adopted pedigree laws, and
another dozen states are considering similar drug safety regulations.
In order to support interoperability, officials from
the two companies submitted formats to the Pedigree Messaging Work Group
of industry consortium EPCglobal in September 2005. The companies collaborated
with industry participants toward ratification of an industry standard
which is expected this spring. Technical teams from both companies
have reviewed and discussed each other’s formats and have certified
that the core elements exist to process each other’s data.
“The work we have done, both in the formal standards
processes and directly, ensures pharmaceutical companies, wholesalers
and pharmacies that pedigree systems will work seamlessly with suppliers
and customers, now and in the future” said SupplyScape President Shabbir
Dahod.
The two companies worked together not only to meet
pedigree requirements, but also to clarify business processes related
to pedigree adoption.
“To achieve an intelligent and secure supply chain,
our customers must be able to receive electronic pedigrees from their
suppliers and transmit pedigrees to their customers,” said Jeff Richards,
Vice President of Intelligent Supply Chain Services with VeriSign.
“Our collaboration demonstrates our commitment to meet customer requirements
for streamlined supply chain systems that are compliant with the state
regulations.”
About SupplyScape
SupplyScape Corporation provides supply chain security software and
expertise to safeguard the pharmaceutical supply chain. SupplyScape’s
products and services including electronic pedigree and drug serial
number authentication are used by pharmaceutical companies, wholesalers,
distributors, and pharmacies to help protect the drug supply from counterfeits.
For more information, visit www.supplyscape.com.
About VeriSign
VeriSign, Inc. (Nasdaq: VRSN) operates intelligent infrastructure services
that enable businesses and individuals to find, connect, secure, and
transact across today’s complex global networks. Additional news
and information about the company is available at www.verisign.com.
VeriSign® Intelligent Supply Chain Services enable
trusted, secure and scalable information exchange and collaboration
among global supply chain participants. VeriSign’s Electronic
Pedigree Service helps enable distributors, manufacturers, and pharmacies
to implement their compliance strategies. Additional news and
information about the company is available at www.VeriSign.com.
For more information from VeriSign, contact:
VeriSign Media Relations: Pat Burns, pburns@verisign.com,
703-948-4471
VeriSign Investor Relations: Tom McCallum, tmccallum@verisign.com,
650-426-3744
For more information from SupplyScape, contact:
SupplyScape Media Relations: Toni Pommet, toni@supplyscape.com,
781-305-8085 x431
Trademarks
VeriSign and other trademarks, service marks and logos are registered
or unregistered marks of VeriSign, Inc. and its subsidiaries in the
United States and in foreign countries. Copyright © 2006 VeriSign,
Inc. All rights reserved.
Statements in this announcement other than historical
data and information constitute forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E
of the Securities Exchange Act of 1934. These statements involve risks
and uncertainties that could cause VeriSign's actual results to differ
materially from those stated or implied by such forward-looking statements.
The potential risks and uncertainties include, among others, the uncertainty
of future revenue and profitability and potential fluctuations in quarterly
operating results due to such factors as the inability of VeriSign to
successfully develop and market new services and the uncertainty of
whether new services as provided by VeriSign will achieve market acceptance
or result in any revenues. More information about potential factors
that could affect the company's business and financial results is included
in VeriSign's filings with the Securities and Exchange Commission, including
in the company's Annual Report on Form 10-K for the year ended December
31, 2004 and quarterly reports on Form 10-Q. VeriSign undertakes no
obligation to update any of the forward-looking statements after the
date of this press release.
###
Worldwide Sites
